Xiang Long

Title: Innovations of Inventor Xiang Long

Introduction

Xiang Long is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of nanobodies for viral detection and analysis. With a total of three patents to his name, his work has broad implications for public health and disease prevention.

Latest Patents

Xiang Long's latest patents include a nanobody targeting the influenza A virus nucleoprotein and a nucleic acid encoding this nanobody. This innovation utilizes a nanobody phage library and phage screening technology to create a VHH antibody fragment that can specifically bind to the influenza A virus nucleoprotein. The applications of this nanobody extend to the detection and analysis of the influenza A virus, offering promising prospects for early warning systems and environmental monitoring. Additionally, he has developed a preparation method for a single-chain antibody fragment targeting the SARS-CoV-2 nucleocapsid protein. This fragment exhibits high affinity and specificity, making it suitable for various immunoassay platforms related to SARS-CoV-2 detection.

Career Highlights

Xiang Long is affiliated with Nanjing University, where he continues to advance his research in the field of viral detection. His innovative approaches and methodologies have positioned him as a key figure in the development of diagnostic tools for infectious diseases.

Collaborations

Xiang Long collaborates with notable colleagues, including Yi Luo and Shixiang Yang, who contribute to his research endeavors and enhance the impact of his work.

Conclusion

Xiang Long's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to improving public health. His work in developing nanobodies for viral detection is paving the way for more effective diagnostic tools and preventive measures against infectious diseases.